Main author:

Joanne G. Wildenbeest (2 – UMCU)

Work Package:

WP3 - Clinical validation studies (Prospective studies)

PDF file

The PROMISE case-control validation study (study 2) is a prospective monocenter study conducted at UMC Utrecht. The objectives of this study are to validate biomarkers for severity of respiratory syncytial virus (RSV) disease in infants found in the RESCEU infant studies and to validate a new severity score developed by WP1.

Published On: September 21, 2023